首页> 外国专利> A medium compostion for lymphocyte derived from peripheral blood mononuclear cells having anticancer activity and cultivation method using the same

A medium compostion for lymphocyte derived from peripheral blood mononuclear cells having anticancer activity and cultivation method using the same

机译:具有抗癌活性的外周血单核细胞来源的淋巴细胞培养基组合物及其使用方法

摘要

The present invention relates to a culture medium for the culture of anti-cancer activated lymphocytes derived from peripheral blood mononuclear cells, and a method for culturing cancer-activated lymphocytes using the same. More particularly, the present invention relates to a culture medium containing anti-CD3 monoclonal antibody , And anti-CD16 monoclonal antibody was included in the culture medium, the effect of promoting differentiation and mass proliferation of NK cells, NKT cells, and T cells (anti-cancer activated lymphocytes) was confirmed from peripheral blood mononuclear cells. Accordingly, the present invention relates to a culture composition based on the fractionated normal hexane fraction and a method for culturing peripheral blood mononuclear cells using the same. Also, the anti-cancer activated lymphocytes derived from peripheral blood mononuclear cells cultured by the method according to the present invention can be used as a pharmaceutical composition highly effective for cancer treatment. Furthermore, the culture medium composition of the present invention can be used as an anticancer therapy itself, and when a chemical anticancer agent is administered concurrently in a clinical trial, the dose of the conventional anticancer drug can be lowered, and the side effect can be alleviated and the anticancer activity can be greatly improved.
机译:本发明涉及用于培养源自外周血单核细胞的抗癌活化淋巴细胞的培养基,以及使用该培养基培养癌症活化淋巴细胞的方法。更具体地,本发明涉及含有抗CD3单克隆抗体的培养基,并且该培养基中包含抗CD16单克隆抗体,具有促进NK细胞,NKT细胞和T细胞的分化和大量增殖的作用。从外周血单个核细胞中证实了抗癌活性淋巴细胞)。因此,本发明涉及基于分馏的正己烷馏分的培养组合物以及使用该培养组合物培养外周血单核细胞的方法。而且,通过根据本发明的方法培养的源自外周血单核细胞的抗癌活化淋巴细胞可以用作对癌症治疗高度有效的药物组合物。此外,本发明的培养基组合物本身可以用作抗癌疗法,并且在临床试验中同时施用化学抗癌剂时,可以降低常规抗癌药的剂量,并且可以降低副作用。缓和了抗癌活性。

著录项

  • 公开/公告号KR101839413B1

    专利类型

  • 公开/公告日2018-03-16

    原文格式PDF

  • 申请/专利权人 주식회사 제넨셀;

    申请/专利号KR20160113821

  • 发明设计人 강세찬;장선필;

    申请日2016-09-05

  • 分类号C12N5/0783;A61K35/17;

  • 国家 KR

  • 入库时间 2022-08-21 12:38:11

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号